<html><body><div style="color:#000; background-color:#fff; font-family:verdana, helvetica, sans-serif;font-size:10pt"><div style="RIGHT: auto"><SPAN style="RIGHT: auto">Dear KP and all</SPAN></div>
<div style="RIGHT: auto"><SPAN style="RIGHT: auto">I have been reading the exchange of emails regarding characterisation of leishmania isolates from Himachal in India by Dr Sharma and KP. Actually I have also been associated with that though very briefly and had a chance to try-n-culture some of isolates sent by Dr Sharma. The cultures became positive but we failed to establish good passagable cultures from any of aspirates/biopsy specimen sent by Dr Sharma, although my lab has been able to establish some good number of primaray cultures from spleen/BM aspirates of Ld strains in Chandigarh, although almost all the source patients belonged to Bihar originally for these. So there is definetely some thing very different about the leishmania strains that are circulating in that geographical area of India. we also had a chance to use a specific PCR (that was developed in my lab and can distinguish between an Ld and any cutaneous
strain). we found about 40-50% of isolates got Ld specific amplification while others didnot show Ld genome. So I do believe, there is a mix of Ld and some cutaneous strain in that area which KP is also refering too. It needs to be investigated further... I know Dr Sharma is on to such effort soon...</SPAN></div>
<div style="RIGHT: auto"><SPAN style="RIGHT: auto"></SPAN> </div>
<div style="RIGHT: auto"><SPAN style="RIGHT: auto">regards</SPAN></div>
<div style="RIGHT: auto"><SPAN style="RIGHT: auto">sunil</SPAN></div>
<DIV></DIV>
<DIV style="RIGHT: auto"> </DIV>
<div style="RIGHT: auto"><EM><FONT color=#00007f>Dr Sunil K.Arora<BR>Professor <BR>In Charge HIV diagnostic and Disease Monitoring Laboratory<VAR id=yui-ie-cursor></VAR><BR>Department of Immunopathology<BR>PGIMER, Chandigarh-160 012<BR>Ph.: 0091-172-2755192(Off)<BR>FAX: 0091-172-2744401, 2745078<BR>Ph:+91-172-2732863 (Res); 9872866087 (cell)<BR>email: skarora_in@yahoo.com; skarorain@gmail.com</FONT></EM><BR></div>
<DIV style="FONT-FAMILY: verdana, helvetica, sans-serif; FONT-SIZE: 10pt">
<DIV style="FONT-FAMILY: times new roman, new york, times, serif; FONT-SIZE: 12pt"><FONT size=2 face=Arial>
<DIV style="BORDER-BOTTOM: #ccc 1px solid; BORDER-LEFT: #ccc 1px solid; PADDING-BOTTOM: 0px; LINE-HEIGHT: 0; MARGIN: 5px 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 0px; BORDER-TOP: #ccc 1px solid; BORDER-RIGHT: #ccc 1px solid; PADDING-TOP: 0px" class=hr contentEditable=false readonly="true"></DIV><B><SPAN style="FONT-WEIGHT: bold">From:</SPAN></B> "Chang, Kwang-Poo" <KwangPoo.Chang@rosalindfranklin.edu><BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> mmukhtar@tropmedicine.org; Sharman <nandlals@hotmail.com>; Petr Volf <volf@cesnet.cz>; Hiro Goto <hgoto@usp.br>; elfadil abass <elfadil_abass@yahoo.com>; vishwamohan_katoch@yahoo.co.in; lalit Kant ICMR <lalitkant@icmr.org.in><BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> Friday, June 3, 2011 12:03 AM<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> Re: [Leish-l]
inquiry<BR></FONT><BR>
<DIV id=yiv1847465988>
<STYLE>
<!--#yiv1847465988 a:link
{}
#yiv1847465988 span.yiv1847465988MSOHYPERLINK
{}
#yiv1847465988 a:visited
{}
#yiv1847465988 span.yiv1847465988MSOHYPERLINKFOLLOWED
{}
#yiv1847465988 p
{}
#yiv1847465988
_filtered #yiv1847465988 {font-family:Tahoma;panose-1:2 11 6 4 3 5 4 4 2 4;}
_filtered #yiv1847465988 {font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;}
#yiv1847465988
#yiv1847465988 p.yiv1847465988MsoNormal, #yiv1847465988 li.yiv1847465988MsoNormal, #yiv1847465988 div.yiv1847465988MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman";}
#yiv1847465988 a:link, #yiv1847465988 span.yiv1847465988MsoHyperlink
{color:blue;text-decoration:underline;}
#yiv1847465988 a:visited, #yiv1847465988 span.yiv1847465988MsoHyperlinkFollowed
{color:purple;text-decoration:underline;}
#yiv1847465988 p
{margin-right:0in;margin-left:0in;font-size:12.0pt;font-family:"Times New Roman";}
#yiv1847465988 span.yiv1847465988EmailStyle18
{font-family:Calibri;color:#1F497D;}
#yiv1847465988 span.yiv1847465988EmailStyle19
{font-family:Arial;color:navy;}
#yiv1847465988 span.yiv1847465988EmailStyle21
{font-family:Calibri;color:#1F497D;}
#yiv1847465988 span.yiv1847465988EmailStyle22
{font-family:Arial;color:navy;}
_filtered #yiv1847465988 {margin:1.0in 1.0in 1.0in 1.0in;}
#yiv1847465988 div.yiv1847465988Section1
{}
#yiv1847465988
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
_filtered #yiv1847465988 {}
#yiv1847465988 ol
{margin-bottom:0in;}
#yiv1847465988 ul
{margin-bottom:0in;}
-->
</STYLE>
<DIV class=yiv1847465988Section1>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">Dear Maowia,</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">Thanks again for the info.</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">Are there any record available for the number of successful isolations versus the total number attempted for a given endemic site ?</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">KP</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<DIV>
<DIV style="TEXT-ALIGN: center" class=yiv1847465988MsoNormal align=center><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt">
<DIV style="BORDER-BOTTOM: #ccc 1px solid; BORDER-LEFT: #ccc 1px solid; PADDING-BOTTOM: 0px; LINE-HEIGHT: 0; MARGIN: 5px 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 0px; BORDER-TOP: #ccc 1px solid; BORDER-RIGHT: #ccc 1px solid; PADDING-TOP: 0px" class=hr contentEditable=false readonly="true"></DIV></SPAN></FONT></DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> Maowia Mukhtar [mailto: mmukhtar@tropmedicine.org ] <BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> Wednesday, June 01, 2011 10:41 PM<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> Chang, Kwang-Poo; 'Sharman'; 'Petr Volf'; 'Hiro Goto'; 'elfadil abass'; vishwamohan_katoch@yahoo.co.in; 'lalit Kant ICMR'<BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> RE: [Leish-l] inquiry</SPAN></FONT></div></DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">Dear KP,</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">Thanks for your comments and valuable notes. We have a high success rate inc culturing Leishmania from clinical aspirates. We have even succeeded in culturing Leishmania directly from PKDL lesions without using hamsters although the parasite is known to be scarce in these lesions. We have noticed that the rate of success of cultures varies between endemic regions in Sudan as well as between the clinical forms. Sudanese Leishmania donovani is known to be different from the Indian donovani even in their response to antileishmania drugs and in their reaction using different diagnostic serology tests. </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">Best regards</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">Maowia</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<DIV>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Professor Maowia M. Mukhtar</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Institute</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> of Endemic</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Diseases</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">University</FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> of Khartoum</SPAN></FONT></B></SPAN><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"></SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">P.O. Box 11463, khartoum, Sudan</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Mobile</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">; +249912234268</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Fax: +249183779712</SPAN></FONT></B></div></DIV>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<DIV>
<DIV style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #b5c4df 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 3pt">
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> Chang, Kwang-Poo [mailto:KwangPoo.Chang@rosalindfranklin.edu] <BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> 02 June 2011 01:42<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> mmukhtar; Sharman; Petr Volf; Hiro Goto; elfadil abass; vishwamohan_katoch@yahoo.co.in; lalit Kant ICMR<BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br; Chang, Kwang-Poo<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> RE: [Leish-l] inquiry</SPAN></FONT></div></DIV></DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">Dear Maowia,</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">Gald to hear from you with your work-in-progress. May I ask you some questions and share with you some info from my very limited experience with Sudanese L donovani ? Please correct my statements, if inccorrect.</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<OL style="MARGIN-TOP: 0in" type=1>
<LI style="COLOR: navy" class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">“difficult to maintain” means that the promastigotes emerge after incubation of lesion aspirates/punctures in appropriate media and replicate during successive passages, but are low in cell density and easily lost during repetitive passages for continuous cultivation ?</SPAN></FONT></LI></OL>
<div style="MARGIN-LEFT: 0.25in" class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<OL style="MARGIN-TOP: 0in" type=1 start=2>
<LI style="COLOR: navy" class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">“difficult to grow” means that the promastigotes never emerge or emerge after incubation of lesion aspirates/punctures in appropriate media, but subsequently fail to replicate or replicate to a limited extent on subculture ?</SPAN></FONT></LI></OL>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<OL style="MARGIN-TOP: 0in" type=1 start=3>
<LI style="COLOR: navy" class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">What is the rate of success in your attempts to isolate parasites in culture from clinical samples in each endemic site over the years ? </SPAN></FONT></LI></OL>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<OL style="MARGIN-TOP: 0in" type=1 start=4>
<LI style="COLOR: navy" class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">The Sudanese strain used by many in the USA was probably brought over decades ago by Donald Hyneman and established in Syrian Golden hamsters by Leslie Stauber and his students. In the 70’s, I had the good fortune of working with Dennis Dwyer on his S1 or S2 strains of this origin. As widely reported in the literature, this is an excellent model of visceral leishmaniasis, producing typical clinical outcome consistently, including invariable death and splenic LD loads of up to 10<SUP>10</SUP> per heavily infected spleen. I recall I had difficult time to differentiate these splenic amastigotes into promastigotes. I did see some motile promastigotes. While a small number remains viable, many died and appeared as ghosts during the subsequent incubation. This has led me to suspect selection of cultivable clones. In some,
but not all of these cultures, promastigotes eventually became ‘adapted’ to the culture conditions and grew, producing consistently up to ~40 X 10<SUP>6</SUP> cells/ml in 4-5 days in successive passages (starting from ~10<SUP>6</SUP>/ml = ~ 4-5 generation or replication cycles). The stationary phase promastigotes of these cultures no longer produce good infection of hamsters, irrespective of the passage numbers (Isolation of ‘metacyclics” to produce good infection has since been reported in the literature, if I remember correctly). These promastigotes are more similar to the Mediterranean L infantum than to the Indian L donovani of the Bihar region in the sequence of their single-copy protein-coding genes, as probably already shown by many based on sequencing other genetic sites. </SPAN></FONT></LI></OL>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt">KP</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=navy size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: navy; FONT-SIZE: 10pt"> </SPAN></FONT></div>
<DIV>
<DIV style="TEXT-ALIGN: center" class=yiv1847465988MsoNormal align=center><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt">
<DIV style="BORDER-BOTTOM: #ccc 1px solid; BORDER-LEFT: #ccc 1px solid; PADDING-BOTTOM: 0px; LINE-HEIGHT: 0; MARGIN: 5px 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 0px; BORDER-TOP: #ccc 1px solid; BORDER-RIGHT: #ccc 1px solid; PADDING-TOP: 0px" class=hr contentEditable=false readonly="true"></DIV></SPAN></FONT></DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> Maowia Mukhtar [mailto: mmukhtar@tropmedicine.org ] <BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> Tuesday, May 31, 2011 2:30 PM<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> 'Sharman'; 'Petr Volf'; Chang, Kwang-Poo; 'Hiro Goto'; 'elfadil abass'; vishwamohan_katoch@yahoo.co.in; 'lalit Kant ICMR'<BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> RE: [Leish-l] inquiry</SPAN></FONT></div></DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">Dear Colleagues,</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt">We have very interesting experience with Sudanese L.donovani. This group of parasite although are genetically homogenous they still cause diverse clinical forms in Sudan ranging from VL, PKDL, ML to CL. We have isolated L. donovani MON82 from classic cutaneous ulcers and typed them using both isoenzyme and molecular typing techniques. Please check our manuscript (Elamin et al. 2008. </SPAN></FONT><SPAN class=yiv1847465988jrnl><FONT size=1 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 9pt">Trans R Soc <FONT color=#1f497d><SPAN style="COLOR: #1f497d">Trop Med Hyg</SPAN></FONT></SPAN></FONT></SPAN><FONT color=#1f497d size=1 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: #1f497d; FONT-SIZE: 9pt">. 2008 Jan;102(1):54-7.). We have analyzed several virulence genes comparing the isolates from the diverse
clinical forms and they turned to be are highly homologous. Immunologically they induce different immune responses (TH1/TH2). We know the vector of L.donovani VL isolates which is P. orientalis, but we still don’t know the vector of cutaneous L. donovani parasite. We believe the vector plays an important role in the pathogenesis and the outcome of L. donovani infection together with the host immune response and may be some of the parasite virulence factors. We will soon published our data on parasite typing and host immune responses of the diverse clinical forms. </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=1 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: #1f497d; FONT-SIZE: 9pt">Best regards</SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=1 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: #1f497d; FONT-SIZE: 9pt">Maowia</SPAN></FONT><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"></SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<DIV>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Professor Maowia M. Mukhtar</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Institute</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> of Endemic</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Diseases</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">University</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> of Khartoum</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold"></SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">P.O. Box 11463, khartoum, Sudan</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Mobile</SPAN></FONT></B><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">; +249912234268</SPAN></FONT></B></div>
<div class=yiv1847465988MsoNormal><B><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Fax: +249183779712</SPAN></FONT></B></div></DIV>
<div class=yiv1847465988MsoNormal><FONT color=#1f497d size=2 face=Calibri><SPAN style="FONT-FAMILY: Calibri; COLOR: #1f497d; FONT-SIZE: 11pt"> </SPAN></FONT></div>
<DIV>
<DIV style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #b5c4df 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 3pt">
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> leish-l-bounces@lineu.icb.usp.br [mailto:leish-l-bounces@lineu.icb.usp.br] <B><SPAN style="FONT-WEIGHT: bold">On Behalf Of </SPAN></B>Sharman<BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> 31 May 2011 18:13<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> Petr Volf; Chang, Kwang-Poo; Hiro Goto; elfadil abass; vishwamohan_katoch@yahoo.co.in; lalit Kant ICMR<BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> Re: [Leish-l] inquiry</SPAN></FONT></div></DIV></DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face=Calibri><SPAN style="FONT-FAMILY: Calibri; FONT-SIZE: 12pt">Hi Petr,</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face=Calibri><SPAN style="FONT-FAMILY: Calibri; FONT-SIZE: 12pt">Thanks for enclosing the pdf. In fact the strain which we are dealing with is not very difficult to grow but difficult to maintain, It is rK 39 positive and as I mentioned in the conversation below that even the serous exudate from the ulcer is also positive for rK 39 dipstick. In between because of my relocation to a different institute I was little away from this work but I intend to resume this work in couple of months. Although in past we tried to isolate the parasite from sand flies but did not succeed. We will surely attempt again with the techniques described by you and others. Contamination is the problem.</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face=Calibri><SPAN style="FONT-FAMILY: Calibri; FONT-SIZE: 12pt">This particular focus seems to be a complex one.</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face=Calibri><SPAN style="FONT-FAMILY: Calibri; FONT-SIZE: 12pt">NL Sharma</SPAN></FONT> </div></DIV>
<DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> </SPAN></FONT></div></DIV>
<DIV>
<DIV>
<div style="BACKGROUND: whitesmoke" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> <A title=volf@cesnet.cz href="mailto:volf@cesnet.cz" rel=nofollow target=_blank ymailto="mailto:volf@cesnet.cz">Petr Volf</A> </SPAN></FONT></div></DIV>
<DIV>
<div style="BACKGROUND: whitesmoke" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sent:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> Tuesday, May 31, 2011 12:36 PM</SPAN></FONT></div></DIV>
<DIV>
<div style="BACKGROUND: whitesmoke" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> <A title=KwangPoo.Chang@rosalindfranklin.edu href="mailto:KwangPoo.Chang@rosalindfranklin.edu" rel=nofollow target=_blank ymailto="mailto:KwangPoo.Chang@rosalindfranklin.edu">Chang, Kwang-Poo</A> ; <A title="mailto:nandlals@hotmail.com CTRL + Click to follow link" href="mailto:nandlals@hotmail.com" rel=nofollow target=_blank ymailto="mailto:nandlals@hotmail.com">Sharman</A> ; <A title="mailto:hgoto@usp.br CTRL + Click to follow link" href="mailto:hgoto@usp.br" rel=nofollow target=_blank ymailto="mailto:hgoto@usp.br">Hiro Goto</A> ; <A title="mailto:elfadil_abass@yahoo.com CTRL + Click to follow link" href="mailto:elfadil_abass@yahoo.com" rel=nofollow target=_blank
ymailto="mailto:elfadil_abass@yahoo.com">elfadil abass</A> </SPAN></FONT></div></DIV>
<DIV>
<div style="BACKGROUND: whitesmoke" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cc:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> <A title=leish-l@lineu.icb.usp.br href="mailto:leish-l@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</A> </SPAN></FONT></div></DIV>
<DIV>
<div style="BACKGROUND: whitesmoke" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subject:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> Re: [Leish-l] inquiry</SPAN></FONT></div></DIV></DIV></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Hi K.P.,</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">in Cukurova region, Turkey , cutaneous L. infantum (now it seems that we are dealing with L.donovani/L. infantum hybrid) grew very poorely if we isolated them from patients. Only 1 of 25 isolations was succesfull. However, the same strain (confirmed by molecular methods) grew repeatedly and very well if we isolated them from sandflies. It might be useful for Dr. Sharma try to get isolates from sand flies. It is very laborious but very useful, in Cukurova we got about dozen of isolates by this method (all identical).</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Patients are rK39 negative, see attached paper.</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Best wishes</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Petr</SPAN></FONT></div></DIV>
<BLOCKQUOTE style="BORDER-BOTTOM: medium none; BORDER-LEFT: black 1.5pt solid; PADDING-BOTTOM: 0in; MARGIN: 5pt 0in 5pt 3.75pt; PADDING-LEFT: 4pt; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in">
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">----- Original Message ----- </SPAN></FONT></div></DIV>
<DIV>
<div style="BACKGROUND: #e4e4e4" class=yiv1847465988MsoNormal><B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> <A title=KwangPoo.Chang@rosalindfranklin.edu href="mailto:KwangPoo.Chang@rosalindfranklin.edu" rel=nofollow target=_blank ymailto="mailto:KwangPoo.Chang@rosalindfranklin.edu">Chang, Kwang-Poo</A> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To:</SPAN></FONT></B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> <A title=nandlals@hotmail.com href="mailto:nandlals@hotmail.com" rel=nofollow target=_blank ymailto="mailto:nandlals@hotmail.com">Sharman</A> ; <A title=hgoto@usp.br href="mailto:hgoto@usp.br" rel=nofollow target=_blank ymailto="mailto:hgoto@usp.br">Hiro Goto</A> ; <A title=elfadil_abass@yahoo.com href="mailto:elfadil_abass@yahoo.com" rel=nofollow target=_blank ymailto="mailto:elfadil_abass@yahoo.com">elfadil abass</A> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cc:</SPAN></FONT></B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> <A title=leish-l@lineu.icb.usp.br href="mailto:leish-l@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</A> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sent:</SPAN></FONT></B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> Sunday, May 22, 2011 1:39 AM</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subject:</SPAN></FONT></B><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> Re: [Leish-l] inquiry</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV id=yiv1847465988idOWAReplyText41530>
<DIV>
<div class=yiv1847465988MsoNormal><FONT color=black size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt">Dr. NL Sharma has been working on an important CL endemic area along the Satluj River valley to the south of Himalaya in India (Please correct me should I be wrong for anything I said here and below). I had the good fortune of visiting the site several years back courtesy of Dr. Sharma. </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">I believe Dr. Sharma's finding is important, since the parasites there are different from the familiar Indian L donovani in Bihar . The parasites are refratory to in vitro cultivation. They do differentiate into promastigotes and may grow a little, but can't really be subcultured to establish passageable lines. This is very much reminescent of L infantum in the Mediterranean area. I recall Dr. Sharma has also found rK39+ dogs, if I remember correctly. If so, Satluj river valley is endemic to the infantile CL.</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Analyses of several batches of basically clinical CL samples from Dr. Sharma showed evidence of L infantum, but also L tropica as well as a mixture of the two in one sample. This is the same picture we have noted for samples from Hatay , Turkey .</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 12pt">These observations make me wonder a lot about our current knowledge on the clinico-epidemiology based on data collected previously by analyses of cultured promastigotes from one or few 'representative samples'. Nowaday, technology makes it very doable to work with biological samples for Leish DNAs directly from sand flies, patients and reservoir animals.</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=2 face=Arial><SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">KP</SPAN></FONT></div></DIV>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV></DIV>
<DIV id=yiv1847465988idSignature79278>
<DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt"> </SPAN></FONT></div></DIV>
<DIV>
<DIV style="TEXT-ALIGN: center" class=yiv1847465988MsoNormal align=center><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt">
<DIV style="BORDER-BOTTOM: #ccc 1px solid; BORDER-LEFT: #ccc 1px solid; PADDING-BOTTOM: 0px; LINE-HEIGHT: 0; MARGIN: 5px 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 0px; BORDER-TOP: #ccc 1px solid; BORDER-RIGHT: #ccc 1px solid; PADDING-TOP: 0px" class=hr contentEditable=false readonly="true"></DIV></SPAN></FONT></DIV>
<div style="MARGIN-BOTTOM: 12pt" class=yiv1847465988MsoNormal><B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From:</SPAN></FONT></B><FONT size=2 face=Tahoma><SPAN style="FONT-FAMILY: Tahoma; FONT-SIZE: 10pt"> leish-l-bounces@lineu.icb.usp.br on behalf of Sharman<BR><B><SPAN style="FONT-WEIGHT: bold">Sent:</SPAN></B> Fri 5/20/2011 11:31 PM<BR><B><SPAN style="FONT-WEIGHT: bold">To:</SPAN></B> Hiro Goto; elfadil abass<BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Subject:</SPAN></B> Re: [Leish-l] inquiry</SPAN></FONT></div></DIV></DIV>
<DIV>
<div><FONT size=2 face="Times New Roman"><SPAN style="FONT-SIZE: 10pt">Dear all<BR>I agree with Hiro gito, We are working on a focus where the CL is<BR>predominantly caused by L. donovani, and the rK 39 STRIPS GIVE POSITIVE<BR>RESULTS WITH SERA as well as serous exudate from the lesion. The results are<BR>dependent upon species.<BR>NL Sharma<BR><BR>--------------------------------------------------<BR>From: "Hiro Goto" <hgoto@usp.br><BR>Sent: Wednesday, May 18, 2011 12:09 AM<BR>To: "elfadil abass" <elfadil_abass@yahoo.com><BR>Cc: <leish-l@lineu.icb.usp.br><BR>Subject: Re: [Leish-l] inquiry<BR><BR>> Dear all,<BR>> In our oppinion, DAT and rK39 for those samples are not indicated since<BR>> these tests are produced for the diagnosis of visceral leishmaniasis.<BR>> In case of tegumentary leishmaniasis, it is very appropriate the<BR>> observation of J.J. Shaw appointing species specificity of antibody<BR>>
response in these cases. Titers of antibodies are in general low in these<BR>> cases therefore depending on the species, it may result negative. We have<BR>> published a review recently in Expert Rev. Anti Infect. Ther. 8(4),<BR>> 419?433 (2010), Current diagnosis and treatment of cutaneous and<BR>> mucocutaneous leishmaniasis, where we raise this point.<BR>> Hiro Goto<BR>><BR>> Citando elfadil abass <elfadil_abass@yahoo.com>:<BR>><BR>>> Dear all I would recommend using DAT and rK39 strip test to measure<BR>>> antibody<BR>>> responses and to evaluate the diagnostic efficiency for both tests in<BR>>> such group<BR>>> of patients.<BR>>><BR>>> Elfadil Abass<BR>>> ________________________________________________________________________________<BR>>> Institute of Medical Microbiology and Hospital Hygiene<BR>>> Philipps University
Marburg<BR>>> BMFZ / Hans-Meerwein Straße 2<BR>>> D-35033 Marburg , Germany<BR>>> ________________________________________________________________________________<BR>>><BR>>><BR>>><BR>>><BR>>> ________________________________<BR>>> From: Nuha Nuwayri-Salti <racha@aub.edu.lb><BR>>> To: saad saad <saad1426@gmail.com>; "leish-l@lineu.icb.usp.br"<BR>>> <leish-l@lineu.icb.usp.br><BR>>> Sent: Fri, May 13, 2011 9:39:33 AM<BR>>> Subject: Re: [Leish-l] inquiry<BR>>><BR>>> Dear Saad first precaution to take is to separate your samples into<BR>>> several<BR>>> portions each (at least 5 each being no more than a few hundred(200-400)<BR>>> microliters). This is a necessary precaution to avoid freezing and<BR>>> thawing<BR>>> several times the same sample which will be the case should you do<BR>>> different<BR>>>
studies at different times which is unavoidable.<BR>>><BR>>> What you can do is correlate the type(ulcerated, abscess, furuncle<BR>>> etc.. ) the<BR>>> locale, the number and age of lesions with the levels of antibody in the<BR>>> sera of<BR>>> these patgients and also monitor cell mediated immunity with leishmanin<BR>>> skin<BR>>> test!<BR>>> I have just published (in print) an article about having circulating<BR>>> parasites<BR>>> in some of these patients with apparently pure cutaneous disease. It is<BR>>> the<BR>>> first paper that revealed this fact. It would be interesting to confirm<BR>>> or<BR>>> de-confirm this fact repeating what we did.<BR>>> Best wishes<BR>>><BR>>> Nuha Nuwayri-Salti MD<BR>>><BR>>><BR>>><BR>>> AOA<BR>>> Medical Honor
Society<BR>>><BR>>><BR>>><BR>>><BR>>> -----Original Message-----<BR>>> From: leish-l-bounces@lineu.icb.usp.br<BR>>> [<A href="mailto:leish-l-bounces@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:leish-l-bounces@lineu.icb.usp.br">mailto:leish-l-bounces@lineu.icb.usp.br</A>]<BR>>> On Behalf Of saad saad<BR>>> Sent: Friday, April 29, 2011 11:23 PM<BR>>> To: leish-l@lineu.icb.usp.br<BR>>> Subject: [Leish-l] inquiry<BR>>><BR>>> Dear all<BR>>> Hi. i am Saad from Saudi Arabia . i have 60 sera from positive case of<BR>>> CL from south west of the country. I would like to have your<BR>>> recommendations to start a good research line in CL using these sera.<BR>>> Thanks in advance for your help<BR>>> _______________________________________________<BR>>> Leish-l mailing list<BR>>> Leish-l@lineu.icb.usp.br<BR>>>
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<BR>>> _______________________________________________<BR>>> Leish-l mailing list<BR>>> Leish-l@lineu.icb.usp.br<BR>>> <A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR>>><BR>><BR>><BR>><BR>> Profa. Dra. Hiro Goto<BR>> Laboratório de Soroepidemiologia e Imunobiologia<BR>> Instituto de Medicina Tropical de São Paulo , USP<BR>> Av. Dr. Enéas de Carvalho Aguiar, 470, prédio II, quarto andar<BR>> 05403-000 - São Paulo , SP<BR>> Tel. +55-11-3061 7023, 3061 7056 ou 3061 7027<BR>> Fax. +55-11-3061-8270<BR>><BR>> _______________________________________________<BR>> Leish-l mailing list<BR>> Leish-l@lineu.icb.usp.br<BR>> <A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow
target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR>><BR>_______________________________________________<BR>Leish-l mailing list<BR>Leish-l@lineu.icb.usp.br<BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A></SPAN></FONT></div></DIV>
<DIV style="TEXT-ALIGN: center" class=yiv1847465988MsoNormal align=center><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt">
<DIV style="BORDER-BOTTOM: #ccc 1px solid; BORDER-LEFT: #ccc 1px solid; PADDING-BOTTOM: 0px; LINE-HEIGHT: 0; MARGIN: 5px 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 0px; BORDER-TOP: #ccc 1px solid; BORDER-RIGHT: #ccc 1px solid; PADDING-TOP: 0px" class=hr contentEditable=false readonly="true"></DIV></SPAN></FONT></DIV>
<div class=yiv1847465988MsoNormal><FONT size=3 face="Times New Roman"><SPAN style="FONT-SIZE: 12pt">_______________________________________________<BR>Leish-l mailing list<BR>Leish-l@lineu.icb.usp.br<BR>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</SPAN></FONT></div></BLOCKQUOTE></DIV></DIV><BR>_______________________________________________<BR>Leish-l mailing list<BR><A href="mailto:Leish-l@lineu.icb.usp.br" ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR><BR><BR></DIV></DIV></div></body></html>